Tetrodotoxin for Moderate to Severe Cancer Pain: A Randomized, Double Blind, Parallel Design Multicenter Study

2008/02/06 by Neil A. Hagen, Patrick du Souich, Bernard Lapointe +5 · 5 citations
Medicine · #Opioid Use Disorder Treatment #Pain Management and Opioid Use #Pain Mechanisms and Treatments

paper · doi:10.1016/j.jpainsymman.2007.05.011

openalex publication_date 2008/02/06 · crossref created 2008/02/06 · crossref issued 2008/04/01 · crossref published 2008/04/01 · crossref published-print 2008/04/01 · openalex created_date 2016/06/24 · crossref deposited 2025/10/10 · crossref indexed 2026/02/08 · openalex updated_date 2026/07/22

Citations

• Core outcome measures for chronic pain clinical trials: IMMPACT recommendations

Cited by

• Tetrodotoxin: Chemistry, Toxicity, Source, Distribution and Detection
• A Multicentre Open-Label Safety and Efficacy Study of Tetrodotoxin for Cancer Pain
• Tetrodotoxin (TTX) as a Therapeutic Agent for Pain
• The Interplay of Dysregulated pH and Electrolyte Imbalance in Cancer
• Tetrodotoxin [wikipedia]